Belén Garijo (Almansa, 1960) is the CEO of the German giant Merck, which is valued at 240,000 million on the stock market, like Inditex and Banco Santander combined.

Belen Garijo took charge of German drug-to-semiconductor group Merck KGaA with the tailwind of the Covid pandemic, propelling the stock to an all-time high in 2021. Since then, ...

Belén Garijo Thank you very much, Constantin, and welcome, everyone, also from my side to our Q1 earnings call. Please go to Slide 5 of the presentation, starting with the highlights.

German pharmaceutical giant Merck has completed a €3 billion ($3. 5 billion) takeover of US biopharmaceutical company ...

The transaction, finalized following regulatory clearance, includes two FDA-approved rare tumor therapies: Ogsiveo for ...

Belén Garijo, CEO of Merck KGaA, Darmstadt, Germany’s healthcare business, shares her steady-vision strategy in transforming a traditional pharma unit focused on small molecules for chronic disease to ...

CARY, N.C., March 25, 2021 /PRNewswire/ -- The CEO Roundtable on Cancer has elected to its Board of Directors Dr. Belén Garijo, Vice Chair of the Executive Board and Deputy CEO of Merck KGaA ...

Belen Garijo Hi, Matthew. So we have branded [ph] price in October 2014 as you said by 7% and actually the impact on the stocking, on the performance of Q3 is not at all significant.

Belen Garijo has taken over as CEO at German pharmaceuticals giant Merck -- the first woman to singlehandedly run a DAX 30-listed company -- as Europe's top economy debates quotas for greater ...

Belen Garijo, member of the management of the Merck KGaA and CEO of Healthcare, speaks during the opening of a new production hall in Reinbek, Germany, March 2 2017 picture alliance via Getty Image.

DARMSTADT, Germany and PARIS — President and CEO of Merck Serono, Belén Garijo, has been appointed an independent director of L'Oréal. Garijo was appointed to the four-year term during L ...